✦ LIBER ✦

465 DISCUSSION A Phase 1 dose escalating study of ACE-041, a novel inhibitor of ALK-1 mediated angiogenesis, in patients with advanced solid tumors

✍ Scribed by S. Sharma; J.C. Bendell; H. Hurwitz; C.H. Condon; B.J. Thornell; P.L. Slatcher; N.G. Borgstein; M.L. Sherman; M.S. Gordon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I dose escalating study of the a

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Phase I dose escalation study of MK-0457

✍ Anne M. Traynor; Maureen Hewitt; Glenn Liu; Keith T. Flaherty; Jason Clark; Stev 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 252 KB

Phase I dose escalation study of KOS-158

✍ Elaine T. Lam; Sanjay Goel; Larry J. Schaaf; Gillian F. Cropp; Alison L. Hannah; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 280 KB

A phase 1 and dose-finding study of LY25

✍ Wakui, Hiroshi; Yamamoto, Noboru; Kitazono, Satoru; Mizugaki, Hidenori; Nakamich 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 366 KB

Phase 1 study of MLN8054, a selective in

✍ E. Claire Dees; Jeffrey R. Infante; Roger B. Cohen; Bert H. O’Neil; Suzanne Jone 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 328 KB

A phase I, dose-escalation study of the

✍ Hollebecque, A.; Deutsch, E.; Massard, C.; Gomez-Roca, C.; Bahleda, R.; Ribrag, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 445 KB